Kalypsys
Shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas.
est. 2001
Regor Therapeutics Group
We aspire to be a world class innovative drug discovery company from China.
39 employees · est. 2018 · Shanghai, China
Kalypsys is the older company (2001 vs 2018).
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Kalypsys | Regor Therapeutics Group |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | Shanghai, China |
| Employees | ||
| Employees | Not tracked yet | 39 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Unknown |
| Total Funding | ||
| Total Funding | $171.00M | $140.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Drug discovery and development, Preclinical candidate optimization, Clinical trials and studies, Partnerships with pharmaceutical companies, Licensing of drug candidates |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biotechnology firms, Healthcare providers, Oncologists, Researchers in metabolic and immunological diseases |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Drug Development, Therapeutic Areas, Automated Technologies, Pathway-based, Biology, Chemistry, Informatics, Integrated Technologies, Comprehensive Services | Drug Discovery, Clinical-Stage Company, Innovative Medicines, Oncology, Immunology, Metabolic Disorders, CARD Platform, Structural Biology, Computational Chemistry, Therapeutic Biology, Medicinal Chemistry, Clinical Development, New Drug Innovation, First-in-Class Molecules, Best-in-Class Molecules |
| Website | ||
| Website | kalypsys.com | regor.com |
About Kalypsys
Kalypsys is a biotechnology company founded in 2001 that is focused on shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas. The company's slogan reflects its commitment to leveraging pathway-based drug discovery an...
About Regor Therapeutics Group
Regor Therapeutics Group, founded in 2018 and based in China, aims to position itself as a leader in innovative drug discovery. With a focus on oncology, immunology, and metabolic disorders, the company leverages its proprietary CARD (Computer Accelerated Rational Discovery) Platform to develop clin...
We will tell you when either one moves
BounceWatch watches Kalypsys and Regor Therapeutics Group for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kalypsys and Regor Therapeutics Gro... — by email.
Frequently Asked Questions
Compare Kalypsys with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kalypsys on 11 Sep 2024, and Regor Therapeutics Group on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.